highly significantP < 0.001
In LUAD, there was also a highly significant difference between stage I clinical pancreatic cancer samples and stages II and III clinical pancreatic cancer samples ( P < 0.001), and stages I and IV clinical pancreatic cancer samples had a significant difference ( P < 0.05) ( Figure 5F and Supplementary Figure 4 ).